Compare · LFMD vs PRVA
LFMD vs PRVA
Side-by-side comparison of LifeMD Inc. (LFMD) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFMD and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $2.60B, about 11.8x LFMD ($220.5M).
- Over the past year, LFMD is down 61.0% and PRVA is down 7.5% - PRVA leads by 53.5 points.
- PRVA has been more active in the news (14 items in the past 4 weeks vs 5 for LFMD).
- PRVA has more recent analyst coverage (25 ratings vs 11 for LFMD).
- Company
- LifeMD Inc.
- Privia Health Group Inc.
- Price
- $4.80+5.37%
- $21.30+3.07%
- Market cap
- $220.5M
- $2.60B
- 1M return
- -6.15%
- -12.31%
- 1Y return
- -60.95%
- -7.45%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 5
- 14
- Recent ratings
- 11
- 25
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest LFMD
- Chief Technology Officer Sripad Umesh was granted 75,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Sripad Umesh
- LifeMD Appoints Umesh Sripad as Chief Technology Officer
- LifeMD to Participate in Upcoming Investor Conferences
- Chief Financial Officer Kavthekar Atul was granted 337,500 shares (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEFA14A filed by LifeMD Inc.
- SEC Form DEFA14A filed by LifeMD Inc.
- SEC Form DEF 14A filed by LifeMD Inc.
Latest PRVA
- Privia Health Enters New Jersey
- Director Soistman Francis S Jr was granted 8,463 shares (SEC Form 4)
- Director Berberian Lance was granted 8,463 shares, increasing direct ownership by 110% to 16,131 units (SEC Form 4)
- Director Cocozza Nancy G was granted 8,463 shares, increasing direct ownership by 25% to 42,814 units (SEC Form 4)
- Director Kimmet Pamela O was granted 8,463 shares, increasing direct ownership by 33% to 34,172 units (SEC Form 4)
- Director Mccarthy Thomas A was granted 8,463 shares, increasing direct ownership by 43% to 27,983 units (SEC Form 4)
- Director King David P was granted 8,463 shares, increasing direct ownership by 20% to 50,775 units (SEC Form 4)
- Director Ryu Jaewon was granted 8,463 shares, increasing direct ownership by 22% to 47,110 units (SEC Form 4)
- Director Morris Matthew Shawn was granted 8,463 shares, increasing direct ownership by 12% to 76,651 units (SEC Form 4)
- SEC Form 3 filed by new insider Soistman Francis S Jr